Research map: Pathological Complete Response in a Patient With HER2-Negative Esophagogastric Junction Cancer Undergoing Conversion-Intent Surgery After Ramucirumab Plus Paclitaxel Following Nivolumab-Based Chemotherapy: A Case Report

Back to the article

Papers in this map

  1. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial · Yelena Yuriy Janjigian · 2021 · 3119 citations · Cited by this paper
  2. Characteristics and Outcomes of Patients With Malignancies Prior to Colorectal Cancer: A Propensity Score Matched Analysis · 2026 · Related
  3. International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO‐GC‐1) · Kazuhiro Yoshida · 2021 · 171 citations · Cited by this paper
  4. Treatment Outcomes and Prognostic Factors in Patients With Pancreatic Adenosquamous Carcinoma: a Single-Center Retrospective Study · 2026 · Related
  5. Functional benefits of the double flap technique after proximal gastrectomy for gastric cancer · Zenichiro Saze · 2021 · 38 citations · Cited by this paper
  6. Trends in Pancreatic Cancer Incidence, Mortality and Net Survival: A Population-Based Analysis in Zurich (Switzerland), 1981–2021 · 2026 · Related
  7. Double tract reconstruction versus double flap technique: short-term clinical outcomes after laparoscopic proximal gastrectomy for early gastric cancer · Byunghyuk Yu · 2022 · 35 citations · Cited by this paper
  8. Factors Associated with Improved Survival for Stage I and II Pancreatic Adenocarcinoma Utilizing the National Cancer Database · 2026 · Related
  9. Efficacy of Cytotoxic Agents After Progression on Anti-PD-(L)1 Antibody for Pre-treated Metastatic Gastric Cancer · Kyoko Kato · 2020 · 21 citations · Cited by this paper
  10. Access or Engagement: The Potential Role of Financial Incentives in Colorectal Cancer Screening · 2026 · Related
  11. Comparison of changes in body-fat mass and reflux esophagitis among reconstruction methods for proximal gastrectomy · Erica Nishimura · 2022 · 20 citations · Cited by this paper
  12. Comment on “Efficacy of Radiotherapy Combined with Immunotherapy in MSS/pMMR Metastatic Colorectal Cancer: A Propensity-Matched Retrospective Study” · 2026 · Related
  13. Transition of the PD‑1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re‑challenge · Taku Nose · 2022 · 11 citations · Cited by this paper
  14. Safety of Immune-Targeted Therapy in Patients with Hepatocellular Carcinoma in the Real-World · 2026 · Related
  15. Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational study · Yukiya Narita · 2023 · 10 citations · Cited by this paper
  16. Who Truly Benefits from Anti-EGFR Rechallenge in Metastatic Colorectal Cancer? From Clinical Enrichment to ctDNA-Guided Molecular Hyperselection · 2026 · Related
  17. Successful Conversion Surgery for Advanced Gastric Cancer With Multiple Liver Metastases Following Ramucirumab Plus Paclitaxel Combination Treatment · Tsutomu Namikawa · 2021 · 6 citations · Cited by this paper
  18. Gastric Cancer Incidence in Iran: Trends and Projections to 2030 based on Global Burden of Disease 2021 Estimates · 2026 · Related
  19. Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report · Kosuke Fukuda · 2022 · 6 citations · Cited by this paper
  20. Redefining First-Line HER2-Positive Advanced Gastric Cancer: From Trastuzumab-Based Chemoimmunotherapy to Zanidatamab and Next-Generation HER2 Targeting · 2026 · Related
  21. [A multicenter retrospective study on the efficacy of different anti-reflux reconstruction methods after proximal gastrectomy for gastric cancer]. · Lu Yang · 2022 · 5 citations · Cited by this paper
  22. Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab · Toshihiko Matsumoto · 2025 · 5 citations · Cited by this paper
  23. Unresectable Advanced Gastric Cancer with Skin Invasion followed by Total Gastrectomy after Second-Line Chemotherapy · Hidenori Maki · 2019 · 4 citations · Cited by this paper
  24. Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB HER2-negative Gastric Cancer · Yudai Hojo · 2025 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)